Florent Arregle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Florent Arregle has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Gilbert Habib
Cardiology Department, APHM, La Timone Hospital, Boulevard Jean Moulin, Marseille, France
4 shared publications Mary Philip
Cardiology Department, Service de Cardiologie APHM, La Timone Hospital , Boulevard Jean Moulin, 13005 Marseille , France
4 shared publicationsAlberto Riberi
Department of Cardiac Surgery, La Timone Hospital , Marseille , France
3 shared publicationsDidier Raoult
Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection , Marseille , France
3 shared publicationsFrederique Gouriet
Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection , Marseille , France
3 shared publicationsJean Paul Casalta
Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection , Marseille , France
3 shared publications
Latest Publications
- Open Access
- 17 April 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (4) , 86
Impact of the SARS-CoV-2 Pandemic on the Management and Prognosis of Infective Endocarditis
Background: Infective endocarditis (IE) is a serious condition which is difficult to diagnose and to treat, both medically and surgically. Objectives: The objective of this study was to evaluate the impact of the SARS-CoV-2 pandemic on the management of patients with IE. Methods: We conducted a single-centre retrospective study including patients hospitalized for IE during the pandemic (Group 2) compared with the same period the year before (Group 1). We compared clinical, laboratory, imagery, therapeutic, and patient outcomes between the two groups. Results: A total of 283 patients were managed for possible or definite IE (164 in Group 1 and 119 in Group 2). There were more intravenous drug-related IE patients in Group 2 (p = 0.009). There was no significant difference in surgery including intra-cardiac device extraction (p = 0.412) or time to surgery (p = 0.894). The one-year mortality was similar in both groups (16% versus 17.7%, p = 0.704). The recurrence rate was not significantly different between the two groups (5.9% in Group 2 versus 9.1% in Group 1, p = 0.311). Conclusions: The SARS-CoV-2 pandemic did not appear to have had a negative impact on the management of patients with IE. Maintenance of the activities of the endocarditis team within the referral centre probably contributed to this result. Nevertheless, the high proportion of intravenous drug-addicted patients in the pandemic cohort suggests that the SARS-CoV-2 pandemic had a major psychosocial impact.
- 17 April 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (4) , 86
Open AccessImpact of the SARS-CoV-2 Pandemic on the Management and Prognosis of Infective Endocarditis
Background: Infective endocarditis (IE) is a serious condition which is difficult to diagnose and to treat, both medically and surgically. Objectives: The objective of this study was to evaluate the impact of the SARS-CoV-2 pandemic on the management of patients with IE. Methods: We conducted a single-centre retrospective study including patients hospitalized for IE during the pandemic (Group 2) compared with the same period the year before (Group 1). We compared clinical, laboratory, imagery, therapeutic, and patient outcomes between the two groups. Results: A total of 283 patients were managed for possible or definite IE (164 in Group 1 and 119 in Group 2). There were more intravenous drug-related IE patients in Group 2 (p = 0.009). There was no significant difference in surgery including intra-cardiac device extraction (p = 0.412) or time to surgery (p = 0.894). The one-year mortality was similar in both groups (16% versus 17.7%, p = 0.704). The recurrence rate was not significantly different between the two groups (5.9% in Group 2 versus 9.1% in Group 1, p = 0.311). Conclusions: The SARS-CoV-2 pandemic did not appear to have had a negative impact on the management of patients with IE. Maintenance of the activities of the endocarditis team within the referral centre probably contributed to this result. Nevertheless, the high proportion of intravenous drug-addicted patients in the pandemic cohort suggests that the SARS-CoV-2 pandemic had a major psychosocial impact.
- 26 October 2023
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 17 (6) , e19-e20
Intra-pericardial rupture of a caseous calcified mass of the mitral annulus
- 26 October 2023
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 17 (6) , e19-e20
Intra-pericardial rupture of a caseous calcified mass of the mitral annulus
- 28 July 2022
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 11 (9) , 672-681
Influence of the healthcare pathway on the outcome of patients with infective endocarditis
To determine the prognosis of patients treated for infective endocarditis (IE) according to their healthcare pathway. To assess how the ESC guidelines are implemented concerning the performance of transoesophageal echocardiography, the use of antibiotic therapy, and the performance of valve surgery; and to compare the epidemiological profile of IE according to the type of centres in which the patients are hospitalized. In a prospective multicentric study including 22 hospitals in the South-East of France, 342 patients were classified into three groups according to their healthcare pathway: 119 patients diagnosed and taken care entirely in a reference centre or hospital with cardiac surgery [Referral Center (RC) group], 111 patients diagnosed and initially taken care in a non-RC (NRC), then referred in a centre including cardiac surgery [transferred to the Referral Center (TRC) group] and 112 patients totally taken care in the NRC (NRC group). One-year mortality was 26% (88 deaths) and was not significantly different between Groups 1 and 2 (20 vs. 21%, P = 0.83). Patients in the NRC group had a higher mortality (37%) compared with patients in the RC and TRC groups (P < 0.001). ESC guidelines were not implemented similarly depending on the healthcare pathway (P = 0.04). Patients in the NRC group were significantly older (P < 0.001) and had more comorbidities (P < 0.001) than patients treated in referral centres. Prognosis of patients with IE is influenced by their healthcare pathway. Patients treated exclusively in NRC have a worse prognosis than patients treated in referral or surgical centres.
- 28 July 2022
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 11 (9) , 672-681
Influence of the healthcare pathway on the outcome of patients with infective endocarditis
To determine the prognosis of patients treated for infective endocarditis (IE) according to their healthcare pathway. To assess how the ESC guidelines are implemented concerning the performance of transoesophageal echocardiography, the use of antibiotic therapy, and the performance of valve surgery; and to compare the epidemiological profile of IE according to the type of centres in which the patients are hospitalized. In a prospective multicentric study including 22 hospitals in the South-East of France, 342 patients were classified into three groups according to their healthcare pathway: 119 patients diagnosed and taken care entirely in a reference centre or hospital with cardiac surgery [Referral Center (RC) group], 111 patients diagnosed and initially taken care in a non-RC (NRC), then referred in a centre including cardiac surgery [transferred to the Referral Center (TRC) group] and 112 patients totally taken care in the NRC (NRC group). One-year mortality was 26% (88 deaths) and was not significantly different between Groups 1 and 2 (20 vs. 21%, P = 0.83). Patients in the NRC group had a higher mortality (37%) compared with patients in the RC and TRC groups (P < 0.001). ESC guidelines were not implemented similarly depending on the healthcare pathway (P = 0.04). Patients in the NRC group were significantly older (P < 0.001) and had more comorbidities (P < 0.001) than patients treated in referral centres. Prognosis of patients with IE is influenced by their healthcare pathway. Patients treated exclusively in NRC have a worse prognosis than patients treated in referral or surgical centres.
- 23 February 2022
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 115 (3) , 160-168
Mitral valve repair is better than mitral valve replacement in native mitral valve endocarditis: Results from a prospective matched cohort
- 23 February 2022
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 115 (3) , 160-168
Mitral valve repair is better than mitral valve replacement in native mitral valve endocarditis: Results from a prospective matched cohort
- 1 March 2021
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 114 (3) , 211-220
18F-fluorodeoxyglucose positron emission tomography/computed tomography for the diagnosis of native valve infective endocarditis: A prospective study
- 1 March 2021
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 114 (3) , 211-220
18F-fluorodeoxyglucose positron emission tomography/computed tomography for the diagnosis of native valve infective endocarditis: A prospective study
- 1 February 2021
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 37 (2) , 292-299
Characteristics and Prognosis of Patients With Left-Sided Native Bivalvular Infective Endocarditis
- 1 February 2021
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 37 (2) , 292-299
Characteristics and Prognosis of Patients With Left-Sided Native Bivalvular Infective Endocarditis